RAPCELDA

Serial Number 87859164
606

Registration Progress

Application Filed
Apr 2, 2018
Under Examination
Apr 9, 2019
Approved for Publication
Feb 12, 2019
Published for Opposition
Feb 12, 2019
Registered

Trademark Image

RAPCELDA

Basic Information

Serial Number
87859164
Filing Date
April 2, 2018
Published for Opposition
February 12, 2019
Abandonment Date
May 16, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 16, 2022
Classes
005

Rights Holder

Stemline Therapeutics, Inc.

03
Address
750 Lexington Ave, 11th Floor
New York, NY 10022

Ownership History

Stemline Therapeutics, Inc.

Original Applicant
03
New York, NY

Stemline Therapeutics, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
May 16, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 16, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 24, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 23, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 23, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 21, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 21, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 26, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 24, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 24, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 24, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 6, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 6, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 6, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 4, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 4, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 4, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 8, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 6, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 6, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 6, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 9, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 12, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 12, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 23, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 7, 2019 ALIE A ASSIGNED TO LIE Loading...
Dec 12, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 11, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 11, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 11, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 3, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 3, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 9, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 5, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agents in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases; diagnostic reagents for medicinal use, namely, for the diagnosis and treatment of cancer and auto-immune diseases

Classification

International Classes
005